{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-003574","form_type":"8-K","ticker":"DBVT","cik":"0001613780","company_name":"DBV Technologies S.A.","filed_at":"2025-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.192952+00:00","generated_at":"2026-05-28T06:46:38.259616+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"DBV Technologies reports positive 3-year EPITOPE OLE data; 68.2% passed food challenge at month 36","bullets":["68.2% of toddlers completed oral food challenge (~12-14 peanut kernels) without meeting stopping criteria at month 36, vs 30.7% at month 12.","83.5% reached eliciting dose ≥1000 mg after three years on Viaskin Peanut, up from 64.2% at month 12.","No treatment-related anaphylaxis or serious TEAEs occurred in year 3; local application-site reactions decreased vs earlier years.","New wear-time analysis: subjects with average daily wear time ≥20 hours (68.4% of active group) showed 75.7% responder rate vs 47.3% for <20 hours.","Data presented at Eastern Food Allergy & Comorbidity Conference; investor webcast on Jan 8, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-003574","json":"https://secwatch.observer/filing/0001193125-25-003574.json","markdown":"https://secwatch.observer/filing/0001193125-25-003574.md","text":"https://secwatch.observer/filing/0001193125-25-003574.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1613780/000119312525003574/0001193125-25-003574-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1613780/000119312525003574/d861550d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T06:46:38.259616+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}